R&D Views & Analysis | pharmaphorum

Views & Analysis

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

Coronavirus pharma news roundup – 31/07/20

Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues.

Views & Analysis

Brits more comfortable sharing data with pharma since COVID-...

New research from MHP Health and ComRes looks at what impacts COVID-19 has had on the public’s health data sharing concerns, and asks how the industry can maintain confidence in data usage

Views & Analysis

Coronavirus pharma news roundup – 24/07/20

With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie ahead.

Views & Analysis

Alnylam’s Anant Murthy on making it as a US biotech in Europ...

Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market.

Views & Analysis

Coronavirus pharma news roundup - 17/07/20

Coronavirus vaccine trials continue – but experts warn that it’s too early to get hopes up. Meanwhile, the rise in digital health looks like it’s here to stay after the pandemic.

Views & Analysis

ICMRA seeks international alignment on COVID-19 product asse...

COVID-19 drugs, vaccines and diagnostics that are developed and tested within new international guidelines can expect rapid assessment and authorisation.

Coronavirus pharma news roundup – 31/07/20

Brits more comfortable sharing data with pharma since COVID-...

Coronavirus pharma news roundup – 24/07/20

Alnylam’s Anant Murthy on making it as a US biotech in Europ...

Coronavirus pharma news roundup - 17/07/20

ICMRA seeks international alignment on COVID-19 product asse...

Fresenius doubles down on biosimilars with big WuXi alliance

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks